ProCE Banner Activity

Where to Next? Future Directions in Treatment Strategies for EGFR-Mutated NSCLC

Slideset Download
Examine emerging data on investigational combinations of EGFR TKIs with immunotherapy, chemotherapy, and other targeted agents for treatment of EGFR­-mutated NSCLC.

Released: September 27, 2018

Expiration: September 26, 2019

No longer available for credit.

Share

Faculty

Helena Yu

Helena Yu, MD

Associate Professor
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by an educational grant from

Pfizer, Inc.

Faculty Disclosure

Primary Author

Helena Yu, MD

Associate Professor
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York